Sequenom Settles on HiSeq for Trisomy 21 Test; Completes Technical Study

At the UBS Global Life Sciences Conference this week, Ron Lindsay, Sequenom's senior vice president of R&D, said that the company recently completed a technical study of its test and will soon embark on a validation study.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.